搜尋結果
Info. dioctahedral smectite. Concise Prescribing Info. Contents. Dioctahedral smectite. Indications/Uses. Smecta Symptomatic treatment of acute diarrhea in childn & infants in addition to oral rehydration, & in adults; chronic diarrhea; pain associated to oesophagus & gastroduodenal & colic disease.
Although guideline-directed medical therapies (GDMTs) for heart failure (HF) with reduced ejection fraction (HFrEF) are effective in reducing risks of mortality and hospitalization for HF (HHF), the clinical burden of HF remains high. At a recent scientific symposium, Dr Yuya Matsue of Juntendo University Graduate School of Medicine in Japan ...
Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...
Adult Prevention of gastroduodenal ulcers induced by nonselective NSAIDs in patients at risk w/ a need for continuous NSAID treatment 1 tab (20 mg) daily. Patients w/ severe hepatic impairment Max: 20 mg daily. 40-mg tab Adult & adolescent ≥12 yr Reflux oesophagitis 1 tab (40 mg) daily for 4 wk, may be increased to 2 tab daily.
Codipront. Manufacturer: CTS Chemical. Distributor: The Glory Medicina. / DKSH. Concise Prescribing Info. Contents. Codeine 30 mg, phenyltoloxamine 10 mg in a resin-bound matrix. Indications/Uses. Relief of cough. Dosage/Direction for Use. Adult & childn >12 yr 1 cap. To be taken in the morning & evening. Administration.
MIMS home. Drugs. Info. Dhamotil. diphenoxylate + atropine. Manufacturer: Teva. Distributor: Zuellig. Concise Prescribing Info. Contents. Diphenoxylate HCl 2.5 mg, atropine sulfate 25 mcg. Indications/Uses. Adjunctive therapy in the management of diarrhea. Dosage/Direction for Use. Adult 1-2 tab tds or qds. Max: 8 tab/day. Administration.
2021年3月9日 · Haematologists from the University of Hong Kong (HKU) have reported initial success with chimeric antigen receptor (CAR) T-cell therapy, treating the first patient in Hong Kong in May 2020 in a global lymphoma trial and another leukaemia patient in October 2020 in
